NCT02628405 2024-07-01R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell LymphomaAcademic and Community Cancer Research UnitedPhase 1/2 Active not recruiting30 enrolled 15 charts
NCT00601718 2017-05-25Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaUniversity of WashingtonPhase 1/2 Completed29 enrolled 10 charts
NCT00829205 2013-08-26Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to TreatmentNational Cancer Institute (NCI)Phase 1/2 Withdrawn
NCT00003406 2013-03-26Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1/2 Completed30 enrolled
NCT00086944 2013-01-24Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1/2 Completed25 enrolled
NCT00004916 2012-06-06Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's LymphomaNorthwestern UniversityPhase 1/2 Completed